Quick Takeaways
- CORZ - Core Scientific, Inc./tx financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q1 2026.
- Headline metric: Return On Equity 30%.
- Info
- Insider Trading
- Financials
- Holders: CORZ, CORZW, CORZZ
Core Scientific, Inc./tx financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2026.
- Symbol
- CORZ, CORZW, CORZZ on Nasdaq, CORZR on OTC
- Location
- Dover, DE
- Fiscal year end
- 31 December
- Latest financial report
- 02 Mar 2026
What Changed
- Return On Equity YoY change: <span class="text-red-600">-84%</span>.
- Most recent SEC facts end date: 26 Feb 2026.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Official SEC Source
Based on latest 10-Q/10-K
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original FilingLatest SEC snapshot (2026-02-26) highlights Return On Equity 30.3%, Return On Assets -15.1%, and Operating Margin -77.0%.
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
51.4/100
Caution Confidence medium
Return On Equity
30%
Metric score 100.0/100
Return On Assets
-15%
Metric score 0.0/100
Financial Health
- Current Ratio
- 1.15x
- Debt to Equity
- -3.12x
Strengths
Return On Equity, Current Ratio, and NetIncomeLoss YoY
Watchpoints
Return On Assets, Operating Margin, and Debt-to-equity
Key metrics snapshot
Return On Equity
30%
YoY: -84%
Industry median: -7.7% (n=122)
Return On Assets
-15%
YoY: -89%
Industry median: -10% (n=122)
Operating Margin
-77%
YoY: +177%
Industry median: -110% (n=58)
Current Ratio
1.15x
YoY: -83%
Industry median: 1.28x (n=84)
Debt-to-equity
-3.12x
YoY: +45%
Industry median: 0.33x (n=76)
Revenues YoY
-38%
YoY:
Industry median: 9.9% (n=72)
NetIncomeLoss YoY
80%
YoY:
Industry median: -104% (n=105)
Profitability
| Metric | Latest value | YoY change |
|---|---|---|
| Return On Equity | 30% | -84% |
| Return On Assets | -15% | -89% |
| Operating Margin | -77% | +177% |
Financial Health
| Metric | Latest value | YoY change |
|---|---|---|
| Current Ratio | 1.15x | -83% |
| Debt-to-equity | -3.12x | +45% |
Growth
| Metric | Latest value | YoY change |
|---|---|---|
| Revenues YoY | -38% | |
| NetIncomeLoss YoY | 80% |
Share Metrics
| Metric | Latest value | YoY change |
|---|---|---|
| Entity Common Stock, Shares Outstanding | 315,332,655 | +5.9% |
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY